154 related articles for article (PubMed ID: 19479793)
1. Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.
Schafer E; Chen A; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1127-9. PubMed ID: 19479793
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Lauhan CR; Schiff D; Gloude N
Pediatr Blood Cancer; 2020 Nov; 67(11):e28528. PubMed ID: 32776434
[No Abstract] [Full Text] [Related]
3. Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults.
McThenia SS; Rawwas J; Oliveira JL; Khan SP; Rodriguez V
Pediatr Transplant; 2018 Aug; 22(5):e13213. PubMed ID: 29921021
[TBL] [Abstract][Full Text] [Related]
4. A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation.
Iwaki N; Mochizuki K; Ozaki J; Maeda Y; Kurokawa T
J Clin Exp Hematop; 2020 Jun; 60(2):55-59. PubMed ID: 32404572
[TBL] [Abstract][Full Text] [Related]
5. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.
Voss MH; Lunning MA; Maragulia JC; Papadopoulos EB; Goldberg J; Zelenetz AD; Horwitz SM
Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):8-14. PubMed ID: 23107915
[TBL] [Abstract][Full Text] [Related]
6. Hepatosplenic gamma-delta T-cell lymphoma.
Ferreri AJ; Govi S; Pileri SA
Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
[TBL] [Abstract][Full Text] [Related]
7. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
[No Abstract] [Full Text] [Related]
8. Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial?
Krishnan M; Lunning M
J Oncol Pract; 2019 Jun; 15(6):307-312. PubMed ID: 31185190
[TBL] [Abstract][Full Text] [Related]
9. Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.
Okuni M; Yakushijin K; Uehara K; Ichikawa H; Suto H; Hashimoto A; Tanaka Y; Shinzato I; Sakai R; Mizutani Y; Nagao S; Kurata K; Kakiuchi S; Miyata Y; Inui Y; Saito Y; Kawamoto S; Yamamoto K; Ito M; Matsuoka H; Minami H
Intern Med; 2019 Mar; 58(5):707-712. PubMed ID: 30449784
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma.
Chanan-Khan A; Islam T; Alam A; Miller KC; Gibbs J; Barcos M; Czuczman MS; Paplham P; Hahn T; McCarthy P
Leuk Lymphoma; 2004 Aug; 45(8):1673-5. PubMed ID: 15370223
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma.
Mansour MR; Dogan A; Morris EC; Khwaja A; Linch DC; Mackinnon S; Peggs KS
Bone Marrow Transplant; 2005 May; 35(9):931-4. PubMed ID: 15778731
[No Abstract] [Full Text] [Related]
12. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
[No Abstract] [Full Text] [Related]
13. Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma.
He S; Roberts A; Ritchie D; Grigg A
Leuk Lymphoma; 2007 Jul; 48(7):1448-50. PubMed ID: 17613781
[No Abstract] [Full Text] [Related]
14. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma.
Sumi M; Takeda W; Kaiume H; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Kobayashi H
Leuk Lymphoma; 2015 Apr; 56(4):1140-2. PubMed ID: 25065703
[No Abstract] [Full Text] [Related]
16. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
[TBL] [Abstract][Full Text] [Related]
17. Hepatosplenic alphabeta T cell lymphoma.
Nagai Y; Ikegame K; Mori M; Inoue D; Kimura T; Shimoji S; Togami K; Tabata S; Kurata M; Imai Y; Matsushita A; Nagai K; Ogawa H; Takahashi T
Int J Clin Oncol; 2010 Apr; 15(2):215-9. PubMed ID: 20217452
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic T-cell lymphoma: treatment challenges.
Bron D; De Leval L; Michiels S; Wittnebel S;
Curr Opin Oncol; 2021 Sep; 33(5):406-411. PubMed ID: 34409955
[TBL] [Abstract][Full Text] [Related]
19. Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children.
Lo Nigro L; Munda S; Poli A; Licciardello M; D'Amico S; Di Cataldo A
Pediatr Blood Cancer; 2007 Oct; 49(5):763. PubMed ID: 17120239
[No Abstract] [Full Text] [Related]
20. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
